Literature DB >> 15572545

Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases.

L Welker1, R A Jörres, U Costabel, H Magnussen.   

Abstract

The current authors aimed to quantify how the likelihood for a given diagnosis changes with the knowledge of bronchoalveolar lavage (BAL) cell differentials. As an initial estimate (a priori probability), frequencies of final diagnoses were taken. Using categorisations for cell differentials, a posteriori probabilities were then derived for each disease, according to Bayes. The analysis was performed in three of five groups of diagnoses suspected prior to BAL: interstitial lung disease (ILD; n=710), inflammatory disease (n=583), or lung tumour mimicking ILD (n=455). Overall, out of 1,971 patients, 18.3% had sarcoidosis, 7.7% usual interstitial pneumonia (UIP), 4.4% extrinsic allergic alveolitis (EAA), and 19.0% tumours. In the group with suspected ILD, the likelihood for sarcoidosis increased from 33.7 to 68.1% when lymphocyte numbers were 30-50% and granulocyte numbers were low; the likelihood for UIP increased from 15.8 to 33.3% when lymphocyte numbers were <30% with granulocytes elevated. CD4/CD8 was informative, especially in sarcoidosis and EAA. Despite considerable increases, the likelihood of rare diseases rarely reached appreciable values. Similar results were obtained in the other two groups of suspected diagnoses. In conclusion, these data suggest that bronchoalveolar lavage cell counts per se provide substantial diagnostic information only in relatively frequent diseases, such as sarcoidosis and usual interstitial pneumonia, and are less helpful in infrequent diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15572545     DOI: 10.1183/09031936.04.00101303

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

Review 1.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

2.  Clusterization of patients with idiopathic pulmonary fibrosis with chemokine receptors: a possible role in the diagnostic work-up of idiopathic pulmonary fibrosis?

Authors:  Giuseppe Brunetti; Alberto Malovini; Claudia Testoni; Riccardo Bellazzi; Antonella Balestrino; Antonio Meriggi; Gianna Moscato; Arnaldo Alessandrini; Federica Rivolta; Patrizia Pignatti
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis.

Authors:  Margaret L Salisbury; Barry H Gross; Aamer Chughtai; Mohamed Sayyouh; Ella A Kazerooni; Brian J Bartholmai; Meng Xia; Susan Murray; Jeffrey L Myers; Amir Lagstein; Kristine E Konopka; Elizabeth A Belloli; Jamie S Sheth; Eric S White; Colin Holtze; Fernando J Martinez; Kevin R Flaherty
Journal:  Eur Respir J       Date:  2018-08-16       Impact factor: 16.671

4.  Cytological diagnosis of malignant mesothelioma--improvement by additional analysis of hyaluronic acid in pleural effusions.

Authors:  L Welker; M Müller; O Holz; E Vollmer; H Magnussen; R A Jörres
Journal:  Virchows Arch       Date:  2007-02-15       Impact factor: 4.064

5.  Extrinsic allergic alveolitis: comparative study of the bronchoalveolar lavage profiles and radiological presentation.

Authors:  M Sterclova; M Vasakova; J Dutka; J Kalanin
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

6.  The bronchoalveolar lavage pattern in radiation pneumonitis secondary to radiotherapy for breast cancer.

Authors:  Claudia Lucia Toma; Aneta Serbescu; Mihai Alexe; Luminita Cervis; Diana Ionita; Miron Alexandru Bogdan
Journal:  Maedica (Buchar)       Date:  2010-12

Review 7.  Interstitial lung disease: the diagnostic role of bronchoscopy.

Authors:  Jad Kebbe; Tony Abdo
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

8.  Rituximab-induced hypersensitivity pneumonitis.

Authors:  Adriano R Tonelli; Richard Lottenberg; Robert W Allan; P S Sriram
Journal:  Respiration       Date:  2008-10-09       Impact factor: 3.580

9.  Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers.

Authors:  Gregorino Paone; Alvaro Leone; Sandro Batzella; Vittoria Conti; Francesco Belli; Laura De Marchis; Alice Mannocci; Giovanni Schmid; Claudio Terzano
Journal:  Inflamm Res       Date:  2012-12-23       Impact factor: 4.575

10.  BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity.

Authors:  Edvardas Danila; Laimute Jurgauskiene; Jolita Norkuniene; Radvile Malickaite
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.